HomeACHL • NASDAQ
Achilles Therapeutics PLC
add
$1.43
0.70%
After Hours:(0.70%)+0.010
$1.44
Closed: Mar 14, 5:20:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.42M | 6.92% |
Net income | -19.60M | -17.45% |
Net profit margin | — | — |
Earnings per share | -0.48 | -14.29% |
EBITDA | -19.22M | -7.42% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.05M | -38.59% |
Total assets | 122.68M | -30.03% |
Total liabilities | 19.54M | -10.59% |
Total equity | 103.14M | — |
Shares outstanding | 41.10M | — |
Price to book | 0.57 | — |
Return on assets | -40.21% | — |
Return on capital | -45.03% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.60M | -17.45% |
Cash from operations | -14.26M | -1,523.35% |
Cash from investing | -28.00K | 55.56% |
Cash from financing | 4.00K | -50.00% |
Net change in cash | -9.09M | -154.46% |
Free cash flow | -8.52M | -240.58% |
Previous close
$1.42
Day range
$1.40 - $1.44
Year range
$0.63 - $1.44
Market cap
58.77M USD
Avg Volume
2.24M
Primary exchange
NASDAQ
About
Founded
2016
Website
Employees
210
